BMI View: Opportunities in Kuwait’s healthcare and pharmaceuticals market are limited, given its small population, limited domestic drug production and the high proportion of expatriates. The government funds the majority of healthcare spending – around 80% – but we forecast that private spending will increase, not least due to the government’s decision to raise the fees non-Kuwaiti nationals pay to use the public healthcare system. We expect that the increased income gained will be used to expand public healthcare offerings. Currently many Kuwaitis travel abroad for treatment – a practice the government wants to curtail. The market has a high …
Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=99927.
Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/kuwait-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.
No comments:
Post a Comment